img

Global Biliary Tumor Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Biliary Tumor Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Biliary Tumor is a form of cancer that develops in the bile duct system, which connects the liver, gallbladder, and small intestine, moving bile – a fluid that helps digest fats – to the small intestine.
Biliary Tumor report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biliary Tumor market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Biliary Tumor industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Biliary Tumor key companies include NuCana, NeoGenomics, Novartis, GlaxoSmithKline and Southwest Oncology Group, etc. NuCana, NeoGenomics, Novartis are top 3 players and held % share in total in 2022.
Biliary Tumor can be divided into Mecine, Surgery and Other,, etc. Mecine is the mainstream product in the market, accounting for % share globally in 2022.
Biliary Tumor is widely used in various fields, such as Hospitals, Clinics and Other,, etc. Hospitals provides greatest supports to the Biliary Tumor industry development. In 2022, global % share of Biliary Tumor went into Hospitals filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biliary Tumor market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


NuCana
NeoGenomics
Novartis
GlaxoSmithKline
Southwest Oncology Group
Segment by Type
Mecine
Surgery
Other

Segment by Application


Hospitals
Clinics
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biliary Tumor market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biliary Tumor introduction, etc. Biliary Tumor Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Biliary Tumor market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Biliary Tumor
1.1 Biliary Tumor Market Overview
1.1.1 Biliary Tumor Product Scope
1.1.2 Biliary Tumor Market Status and Outlook
1.2 Global Biliary Tumor Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Biliary Tumor Market Size by Region (2024-2034)
1.4 Global Biliary Tumor Historic Market Size by Region (2024-2024)
1.5 Global Biliary Tumor Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Biliary Tumor Market Size (2024-2034)
1.6.1 North America Biliary Tumor Market Size (2024-2034)
1.6.2 Europe Biliary Tumor Market Size (2024-2034)
1.6.3 Asia-Pacific Biliary Tumor Market Size (2024-2034)
1.6.4 Latin America Biliary Tumor Market Size (2024-2034)
1.6.5 Middle East & Africa Biliary Tumor Market Size (2024-2034)
2 Biliary Tumor Market by Type
2.1 Introduction
2.1.1 Mecine
2.1.2 Surgery
2.1.3 Other
2.2 Global Biliary Tumor Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Biliary Tumor Historic Market Size by Type (2024-2024)
2.2.2 Global Biliary Tumor Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Biliary Tumor Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Biliary Tumor Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Biliary Tumor Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Biliary Tumor Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Biliary Tumor Revenue Breakdown by Type (2024-2034)
3 Biliary Tumor Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Other
3.2 Global Biliary Tumor Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Biliary Tumor Historic Market Size by Application (2024-2024)
3.2.2 Global Biliary Tumor Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Biliary Tumor Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Biliary Tumor Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Biliary Tumor Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Biliary Tumor Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Biliary Tumor Revenue Breakdown by Application (2024-2034)
4 Biliary Tumor Competition Analysis by Players
4.1 Global Biliary Tumor Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biliary Tumor as of 2022)
4.3 Date of Key Players Enter into Biliary Tumor Market
4.4 Global Top Players Biliary Tumor Headquarters and Area Served
4.5 Key Players Biliary Tumor Product Solution and Service
4.6 Competitive Status
4.6.1 Biliary Tumor Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 NuCana
5.1.1 NuCana Profile
5.1.2 NuCana Main Business
5.1.3 NuCana Biliary Tumor Products, Services and Solutions
5.1.4 NuCana Biliary Tumor Revenue (US$ Million) & (2024-2024)
5.1.5 NuCana Recent Developments
5.2 NeoGenomics
5.2.1 NeoGenomics Profile
5.2.2 NeoGenomics Main Business
5.2.3 NeoGenomics Biliary Tumor Products, Services and Solutions
5.2.4 NeoGenomics Biliary Tumor Revenue (US$ Million) & (2024-2024)
5.2.5 NeoGenomics Recent Developments
5.3 Novartis
5.3.1 Novartis Profile
5.3.2 Novartis Main Business
5.3.3 Novartis Biliary Tumor Products, Services and Solutions
5.3.4 Novartis Biliary Tumor Revenue (US$ Million) & (2024-2024)
5.3.5 GlaxoSmithKline Recent Developments
5.4 GlaxoSmithKline
5.4.1 GlaxoSmithKline Profile
5.4.2 GlaxoSmithKline Main Business
5.4.3 GlaxoSmithKline Biliary Tumor Products, Services and Solutions
5.4.4 GlaxoSmithKline Biliary Tumor Revenue (US$ Million) & (2024-2024)
5.4.5 GlaxoSmithKline Recent Developments
5.5 Southwest Oncology Group
5.5.1 Southwest Oncology Group Profile
5.5.2 Southwest Oncology Group Main Business
5.5.3 Southwest Oncology Group Biliary Tumor Products, Services and Solutions
5.5.4 Southwest Oncology Group Biliary Tumor Revenue (US$ Million) & (2024-2024)
5.5.5 Southwest Oncology Group Recent Developments
6 North America
6.1 North America Biliary Tumor Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Biliary Tumor Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biliary Tumor Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biliary Tumor Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biliary Tumor Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biliary Tumor Market Dynamics
11.1 Biliary Tumor Industry Trends
11.2 Biliary Tumor Market Drivers
11.3 Biliary Tumor Market Challenges
11.4 Biliary Tumor Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Biliary Tumor Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Biliary Tumor Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Biliary Tumor Market Size Share by Region (2024-2024)
Table 4. Global Biliary Tumor Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Biliary Tumor Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Biliary Tumor Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Biliary Tumor Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Biliary Tumor Revenue Market Share by Type (2024-2024)
Table 9. Global Biliary Tumor Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Biliary Tumor Revenue Market Share by Type (2024-2034)
Table 11. North America Biliary Tumor Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Biliary Tumor Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Biliary Tumor Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Biliary Tumor Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Biliary Tumor Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Biliary Tumor Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Biliary Tumor Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Biliary Tumor Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Biliary Tumor Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Biliary Tumor Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Biliary Tumor Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Biliary Tumor Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Biliary Tumor Revenue Market Share by Application (2024-2024)
Table 24. Global Biliary Tumor Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Biliary Tumor Revenue Market Share by Application (2024-2034)
Table 26. North America Biliary Tumor Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Biliary Tumor Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Biliary Tumor Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Biliary Tumor Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Biliary Tumor Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Biliary Tumor Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Biliary Tumor Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Biliary Tumor Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Biliary Tumor Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Biliary Tumor Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Biliary Tumor Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Biliary Tumor Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biliary Tumor as of 2022)
Table 39. Date of Key Players Enter into Biliary Tumor Market
Table 40. Global Biliary Tumor Key Players Headquarters and Area Served
Table 41. Biliary Tumor Product Solution and Service
Table 42. Global Biliary Tumor Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. NuCana Basic Information List
Table 45. NuCana Description and Business Overview
Table 46. NuCana Biliary Tumor Products, Services and Solutions
Table 47. Revenue (US$ Million) in Biliary Tumor Business of NuCana (2024-2024)
Table 48. NuCana Recent Developments
Table 49. NeoGenomics Basic Information List
Table 50. NeoGenomics Description and Business Overview
Table 51. NeoGenomics Biliary Tumor Products, Services and Solutions
Table 52. Revenue (US$ Million) in Biliary Tumor Business of NeoGenomics (2024-2024)
Table 53. NeoGenomics Recent Developments
Table 54. Novartis Basic Information List
Table 55. Novartis Description and Business Overview
Table 56. Novartis Biliary Tumor Products, Services and Solutions
Table 57. Revenue (US$ Million) in Biliary Tumor Business of Novartis (2024-2024)
Table 58. Novartis Recent Developments
Table 59. GlaxoSmithKline Basic Information List
Table 60. GlaxoSmithKline Description and Business Overview
Table 61. GlaxoSmithKline Biliary Tumor Products, Services and Solutions
Table 62. Revenue (US$ Million) in Biliary Tumor Business of GlaxoSmithKline (2024-2024)
Table 63. GlaxoSmithKline Recent Developments
Table 64. Southwest Oncology Group Basic Information List
Table 65. Southwest Oncology Group Description and Business Overview
Table 66. Southwest Oncology Group Biliary Tumor Products, Services and Solutions
Table 67. Revenue (US$ Million) in Biliary Tumor Business of Southwest Oncology Group (2024-2024)
Table 68. Southwest Oncology Group Recent Developments
Table 69. North America Biliary Tumor Market Size by Country (2024-2024) & (US$ Million)
Table 70. North America Biliary Tumor Market Size by Country (2024-2034) & (US$ Million)
Table 71. Europe Biliary Tumor Market Size by Country (2024-2024) & (US$ Million)
Table 72. Europe Biliary Tumor Market Size by Country (2024-2034) & (US$ Million)
Table 73. Asia-Pacific Biliary Tumor Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 74. Asia-Pacific Biliary Tumor Market Size by Region (2024-2024) & (US$ Million)
Table 75. Asia-Pacific Biliary Tumor Market Size by Region (2024-2034) & (US$ Million)
Table 76. Asia-Pacific Biliary Tumor Market Share by Region (2024-2024)
Table 77. Asia-Pacific Biliary Tumor Market Share by Region (2024-2034)
Table 78. Latin America Biliary Tumor Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 79. Latin America Biliary Tumor Market Size by Country (2024-2024) & (US$ Million)
Table 80. Latin America Biliary Tumor Market Size by Country (2024-2034) & (US$ Million)
Table 81. Middle East & Africa Biliary Tumor Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 82. Middle East & Africa Biliary Tumor Market Size by Country (2024-2024) & (US$ Million)
Table 83. Middle East & Africa Biliary Tumor Market Size by Country (2024-2034) & (US$ Million)
Table 84. Biliary Tumor Market Trends
Table 85. Biliary Tumor Market Drivers
Table 86. Biliary Tumor Market Challenges
Table 87. Biliary Tumor Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biliary Tumor Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Biliary Tumor Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Biliary Tumor Market Share by Regions: 2022 VS 2034
Figure 4. Global Biliary Tumor Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Biliary Tumor Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Biliary Tumor Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Biliary Tumor Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Biliary Tumor Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Biliary Tumor Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Mecine
Figure 11. Global Mecine Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Surgery
Figure 13. Global Surgery Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Other
Figure 15. Global Other Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global Biliary Tumor Market Size Share by Type: 2022 & 2034
Figure 17. North America Biliary Tumor Revenue Market Share by Type (2024-2034)
Figure 18. Europe Biliary Tumor Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific Biliary Tumor Revenue Market Share by Type (2024-2034)
Figure 20. Latin America Biliary Tumor Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa Biliary Tumor Revenue Market Share by Type (2024-2034)
Figure 22. Hospitals Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Clinics Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Other Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Global Biliary Tumor Market Size Share by Application: 2022 & 2034
Figure 26. North America Biliary Tumor Revenue Market Share by Application (2024-2034)
Figure 27. Europe Biliary Tumor Revenue Market Share by Application (2024-2034)
Figure 28. Asia-Pacific Biliary Tumor Revenue Market Share by Application (2024-2034)
Figure 29. Latin America Biliary Tumor Revenue Market Share by Application (2024-2034)
Figure 30. Middle East and Africa Biliary Tumor Revenue Market Share by Application (2024-2034)
Figure 31. Biliary Tumor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 32. Global Top 5 and Top 10 Players Biliary Tumor Market Share in 2022
Figure 33. North America Biliary Tumor Market Share by Country (2024-2034)
Figure 34. U.S. Biliary Tumor Market Size (2024-2034) & (US$ Million)
Figure 35. Canada Biliary Tumor Market Size (2024-2034) & (US$ Million)
Figure 36. Germany Biliary Tumor Market Size (2024-2034) & (US$ Million)
Figure 37. France Biliary Tumor Market Size (2024-2034) & (US$ Million)
Figure 38. U.K. Biliary Tumor Market Size (2024-2034) & (US$ Million)
Figure 39. Italy Biliary Tumor Market Size (2024-2034) & (US$ Million)
Figure 40. Russia Biliary Tumor Market Size (2024-2034) & (US$ Million)
Figure 41. Nordic Countries Biliary Tumor Market Size (2024-2034) & (US$ Million)
Figure 42. Asia-Pacific Biliary Tumor Market Share by Region (2024-2034)
Figure 43. China Biliary Tumor Market Size (2024-2034) & (US$ Million)
Figure 44. Japan Biliary Tumor Market Size (2024-2034) & (US$ Million)
Figure 45. South Korea Biliary Tumor Market Size (2024-2034) & (US$ Million)
Figure 46. Southeast Asia Biliary Tumor Market Size (2024-2034) & (US$ Million)
Figure 47. India Biliary Tumor Market Size (2024-2034) & (US$ Million)
Figure 48. Australia Biliary Tumor Market Size (2024-2034) & (US$ Million)
Figure 49. Latin America Biliary Tumor Market Share by Country (2024-2034)
Figure 50. Mexico Biliary Tumor Market Size (2024-2034) & (US$ Million)
Figure 51. Brazil Biliary Tumor Market Size (2024-2034) & (US$ Million)
Figure 52. Middle East & Africa Biliary Tumor Market Share by Country (2024-2034)
Figure 53. Turkey Biliary Tumor Market Size (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia Biliary Tumor Market Size (2024-2034) & (US$ Million)
Figure 55. UAE Biliary Tumor Market Size (2024-2034) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report